{"title": "OHSU COVID-19 Funding Alerts: Week of February 25, 2021 | OHSU Research News", "author": "Full Biography", "url": "https://blogs.ohsu.edu/researchnews/2021/02/25/ohsu-covid-19-funding-alerts-week-of-february-25-2021/", "hostname": "ohsu.edu", "description": null, "sitename": "OHSU Research News | Research News at OHSU", "date": "2021-02-25", "cleaned_text": "is compiling a running list of COVID-19 research opportunities. We publish the list every Thursday. A Featured Opportunities Simons Foundation Autism Research Initiative [Maternal COVID-19 as a potential risk for autism: Supplemental funding for ongoing pregnancy cohorts](https://www.sfari.org/grant/maternal-covid-19-as-a-potential-risk-for-autism-supplemental-funding-for-ongoing-pregnancy-cohorts-request-for-applications/?tab=rfa) What: Supplements funding from other agencies for ongoing pregnancy cohorts to broaden biospecimen collection and to extend post-natal family tracking so they can be leveraged in future research to understand the effects of gestational infection and inflammation on autism risk in children Who should apply: Researcher who have existing pregnancy cohorts who would like to study the effects of COVID-19 infection during pregnancy Award: Up to $250,000 for single sites and up to $400,000 for two or more sites/three years Deadline: March 12, 2021 This organization is on the [President's List](https://o2.ohsu.edu/foundations/research-program-grants/ohsu-presidents-list/index.cfm); submit a [notice of intent form](https://app.smartsheet.com/b/form?EQBCT=b4b914967b774308b1947bbf8ab27b15) before applying NIGMS [NOSI: Urgent Competitive Revisions to IDeA and NARCH Programs for SARS-CoV-2 Surveillance Studies](https://grants.nih.gov/grants/guide/notice-files/NOT-GM-21-031.html) What: Funds to supplement active Institutional Development Award (IDeA, P20, P30, and U54) and Native American Research Centers for Health (NARCH) (S06) awards for surveillance studies of SARS-CoV-2 viral strains Who should apply: Active grantees of IDeA, P20, P30, and U54 and Native American Research Centers for Health (NARCH) (S06) awards Award: Up to $500,000/one year Deadline: March 31, 2021, 5 p.m. PT NIH NIH Guidance AHRQ [Guide Notice on Exception to the Use of the Single IRB Review Requirements During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency](https://grants.nih.gov/grants/guide/notice-files/NOT-HS-21-002.html) Multiple NIH Organizations [Notice of Temporary Extension of Eligibility for the BRAIN Initiative Diversity K99/R00 Career Transition Award During the COVID-19 Pandemic](https://grants.nih.gov/grants/guide/notice-files/NOT-NS-21-004.html) What: The BRAIN Initiative will be providing up to a two-receipt cycle extension of eligibility for prospective applicants to the BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00) through February/March 2021 due dates NIAID [Notice to Extend Eligibility for Submission of NIAID K99 /R00 Pathway to Independence Award due to COVID-related Disruptions](https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-068.html) What: NIAID will extend eligibility for submission of K99/R00 applications due to COVID-related disruptions NIDDK [Temporary Extension of Eligibility for the NIDDK K01 Mentored Research Scientist Development Award During the COVID-19 Pandemic](https://grants.nih.gov/grants/guide/notice-files/NOT-DK-20-054.html) What: NIDDK will be providing up to a two-receipt cycle extension (roughly eight additional months) of eligibility for prospective applicants meeting the requirements for submission of a K01 application from the time period covered by the June/July 2020 due dates through the February/March 2021 due dates Office of The Director [Exceptions to Use of a Single IRB During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency](https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-006.html) What: NIH-funded research studies subject to the 2018 requirements for the Federal Policy for the Protection of Human Subjects and its cooperative research provision and that are ongoing or initially reviewed by the Institutional Review Board during the COVID-19 public health emergency may request an exception to the use of a single IRB Office of The Director [Extended Guidance for Applicants Preparing Applications During the COVID-19 Pandemic](https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-026.html) What: Notice to extend the guidance that NIH grant applications should NOT include contingency plans that would outline steps needed to recover from temporary, emergency situations, or institutional return-to-the-workplace plans, resulting from the COVID-19 pandemic Office of The Director [Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic](https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-163.html) See also: [Extending the Special Exception to the NIH/AHRQ/NIOSH Material Policy During the COVID-19 Pandemic: August/October 2021 Councils](https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-179.html) Office of The Director [Guidance for Applicants Preparing Applications for the Fall 2020 Due Dates During the COVID-19 Pandemic](https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-122.html) What: Guidance for investigators and institutions preparing NIH grant applications for the May 2021 Council round, beginning with applications submitted for the September 25, 2020 due date Office of The Director [Reminder - Requesting Extensions for Early Career Scientists Whose Career Trajectories Have Been Significantly Impacted by COVID-19](https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-052.html) What: Reminder that NIH is providing an opportunity for recipients of NIH Fellowship and NIH Career Development awards who have been impacted by COVID-19 to request no-cost and funded extensions Office of the Director [Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic](https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-158.html) What: Due to disruptions caused by the COVID-19 pandemic, NIH will be providing up to a two-receipt cycle extension (roughly eight additional months) of eligibility for prospective applicants meeting the requirements for submission of a K99/R00 application from the time period covered by the June/July 2020 due dates through the February/March 2021 due dates. Under normal circumstances, individuals must have no more than four years of postdoctoral research experience to be eligible to apply for a K99/R00 award NIH Point-of-Care Technology Research Network NIBIB and NIH POCTRN [Fast-Track Program for COVID-19 Test Development and Distribution](https://www.poctrn.org/radx) What: Funding to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public's safe return to normal activities with the help of the Rapid Acceleration of Diagnostics (RADx) technology development program Who should apply: Anyone with a research interest in diagnostics for SARS-CoV-2 Award: Projects are broken into three phases, and funding amount is dependent upon phase; see FOA for more details Deadline: Open on a rolling basis Parent Announcements PA-18-935 Multiple NIH Organizations [Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)](https://grants.nih.gov/grants/guide/pa-files/PA-18-935.html) What: FOA to submit applications for urgent competitive revisions; intended to provide funds for NIH grantees applying to expand the scope of their active grant Who should apply: Anyone with an active grant from one of the participating organizations who can accomplish their research within the competitive segment of the active award Award: No minimum or maximum/within duration of the parent award Deadline: Open dates vary by awarding IC PA-20-135 Multiple NIH Organizations [Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)](https://grants.nih.gov/grants/guide/pa-files/PA-20-135.html) What: : FOA to submit applications for emergency competitive revisions; offers NIH grantees additional funds for research responsive to the 2019-nCoV outbreak that falls within the scope of an ongoing grant Who should apply: Anyone with an active grant from one of the participating organizations, such as the NIAID, who can accomplish their research within the competitive segment of the active award Award: No minimum or maximum/within duration of the parent award Deadline: Open dates vary by awarding IC Applies to PA-18-935 NCI [Notice of National Cancer Institute (NCI) Participation in PA-18-935 \"Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)\"](https://grants.nih.gov/grants/guide/notice-files/NOT-CA-20-048.html) NIMH [NOSI: NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)](https://grants.nih.gov/grants/guide/notice-files/NOT-AG-20-022.html) NIAAA [NOSI: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA](https://grants.nih.gov/grants/guide/notice-files/NOT-AA-20-011.html) NIDA [NOSI regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus](https://grants.nih.gov/grants/guide/notice-files/NOT-DA-20-047.html) NIMH [NOSI regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus](https://grants.nih.gov/grants/guide/notice-files/NOT-MH-20-047.html) NINDS [NOSI: Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System](https://grants.nih.gov/grants/guide/notice-files/NOT-NS-20-051.html) What: Offers competitive revisions to either active parent grants to expand the scope to address research objectives listed in the notice Who should apply: Anyone with an active grant from the listed agencies Award: Dependent upon agency Deadline: NCI: Not listed; NIMH: Open through May 1, 2021; NIDA: Open through March 31, 2021; NIAAA: Open through April 15, 2021; NIMH: Open through April 15, 2021; NINDS: Open through April 15, 2021 NCI [Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the Crisis](https://grants.nih.gov/grants/guide/notice-files/NOT-CA-20-054.html) What: The NCI is considering requests from its funded grantees and cooperative agreement awardees to engage in limited COVID-19 related research using part of their existing NCI-funded resources under certain conditions Who should apply: Current NCI-funded grantees Award: Funding amount must be within the existing award budget/for the duration of the pandemic Deadline: For the duration of the COVID-19 crisis Multiple NIH Organizations [NOSI regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project](https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-129.html) What: Aims to highlight the urgent need for research on SARS-CoV-2 and COVID-19 in individuals with Down syndrome in conjunction with the INCLUDE Project Who should apply: Currently funded grantees under one of the sponsoring organizations Award: Up to $1 million/one year Deadline: March 12, 2021 and July 12, 2021, both 5 p.m. PDT Multiple NIH Organizations [NOSI regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences](https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-097.html) What: Supports research that addresses key social and behavioral questions related to the COVID-19 pandemic including social, behavioral and economic impacts from these containment and mitigation efforts and their downstream health impacts Who should apply: PIs on active grants from one of the participating organizations Award: Generally up to $200,000/up to two years Deadline: Rolling through March 31, 2021 NIEHS [NOSI: NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)](https://grants.nih.gov/grants/guide/notice-files/NOT-ES-20-020.html) What: Supports research to provide insight into the role of environmental exposures in pathogenicity, transmission, individual susceptibility or prevention and intervention strategies Who should apply: Anyone with a research interest in environmental exposures Award: Not specified/up to two years Deadline: Rolling monthly through May 4, 2021 Applies to PA-20-135 NIAID [NOSI regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)](https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-034.html?utm_campaign=+42151182&utm_content=&utm_medium=email&utm_source=govdelivery&utm_term=) What: Offers competitive revisions to NIAID grants for projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2/COVID-19 Who should apply: Anyone with an active grant from the NIAID Award: No minimum or maximum/within duration of the parent award Deadline: Open on a rolling basis through March 25, 2021 NIEHS [NOSI: NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)](https://grants.nih.gov/grants/guide/notice-files/NOT-ES-20-015.html) What: Supports research to provide insight into the role of environmental exposures in pathogenicity, transmission, individual susceptibility or prevention and intervention strategies Who should apply: Anyone with funding through the NIH Microphysiological Systems Program, microphysiological systems programs from across NIH and SBIR/STTR-supported investigators provided the award involves tissue chips Award: Not specified/up to two years Deadline: Rolling monthly through May 4, 2021 NIAID [NOSI regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)](https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-059.html) What: Highlights very specific and limited needs for Competitive Revision applications to active NIAID grants in order to further build the infrastructure that NIAID needs to support the SARS-CoV-2 and COVID-19 research response Who should apply: PIs on active NIAID grants Award: No more than the annual amount of the current parent award/up to two years Deadline: Rolling through July 2, 2021 NCATS [NOSI regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus](https://grants.nih.gov/grants/guide/notice-files/NOT-TR-20-017.html) What: Supports research on the use of microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection Who should apply: Anyone with funding through the NIH Microphysiological Systems Program, microphysiological systems programs from across NIH and SBIR/STTR-supported investigators provided the award involves tissue chips Award: No more the current amount of the parent award/up to two years Deadline: Open through Jan. 25, 2022 FOAs NCATS [Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required)](https://grants.nih.gov/grants/guide/rfa-files/RFA-TR-20-003.html) What: Supports research to repurpose existing therapeutic agents to treat COVID-19 sequelae and associated complications that result from SARS-CoV-2 infections Who should apply: Anyone with a research interest in repurposing therapeutic agents Award: Up to $9 million/up to three years Deadline: Rolling starting Aug. 6, 2020 Multiple NIH Organizations [Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)](https://grants.nih.gov/grants/guide/pa-files/PAR-20-243.html) What: Funding to focus on the role and impact of digital health interventions to address access, reach, delivery, effectiveness, scalability and sustainability of health assessments and interventions for secondary effects that are utilized during and following the pandemic, particularly in populations who experience health disparities Who should apply: Investigators with partnerships with digital health developers and existing digital health delivery platforms Award: Up to $2.25 million/up to three years Deadline: March 2, 2021, 5 p.m. PT NIAAA SARS-CoV-2, COVID-19 and Consequences of Alcohol Use [(R01 Clinical Trial Not Allowed)](https://grants.nih.gov/grants/guide/rfa-files/RFA-AA-21-002.html), [(R03 Clinical Trial Not Allowed)](https://grants.nih.gov/grants/guide/rfa-files/RFA-AA-21-003.html) and [(R21 Clinical Trial Not Allowed)](https://grants.nih.gov/grants/guide/rfa-files/RFA-AA-21-004.html) What: Supports research grants to address urgent, time-sensitive research questions on the relationships between alcohol consumption and COVID-19 related outcomes and consequences Who should apply: Anyone with a research interest in COVID-19 and alcohol use Award: For R01: Up to $750,000/up to three years; For R03: Up to $100,000/up to two years; For R21: Up to $275,000/up to two years Deadline: LOI due: March 14, 2021; Application due: April 14, 2021, 5 p.m. PT NIAID and NIEHS Immune Development in Early Life (IDEaL) [(U01 Clinical Trial Not Allowed)](https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-20-077.html) and [(U19 Clinical Trial Not Allowed)](https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-20-078.html) What: Supports research to define the mechanisms regulating the establishment, development and maintenance of immunity throughout childhood including the impact of pathogenic or commensal microbes or vaccination against infectious diseases, allergens and environmental pollutants on immune ontogeny and function Who should apply: Anyone with a research interest in childhood immune development; PIs of the U01 cannot also be PI on the U19 and vice versa Award: For U01: Up to $2.5 to five years; U19: to $5 to five years Deadline: LOI due: May 4, 2021; Application due: June 4, 2021, 5 p.m. PT Other Notices of Special Interest NCATS [NOSI: Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need](https://grants.nih.gov/grants/guide/notice-files/NOT-TR-20-011.html) What: Solicits applications for Administrative to UL1, U01, and R21 awards (through [PA-18-591](https://grants.nih.gov/grants/guide/pa-files/PA-18-591.html)), Collaborative Innovation U01 and R21 awards (through [PAR-19-099](https://grants.nih.gov/grants/guide/pa-files/PAR-19-099.html) and [PAR-19-100](https://grants.nih.gov/grants/guide/pa-files/PAR-19-100.html), respectively), and Competitive Revisions for UL1 awards for each of the non-administrative supplement awards (through [PAR-19-337](https://grants.nih.gov/grants/guide/pa-files/PAR-19-337.html)) Who should apply: Anyone with an active grant with an activity code listed above from the NCATS Award: Dependent upon FOA you apply through Deadline: Dependent FOA you apply through NCATS [NOSI: Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)](https://grants.nih.gov/grants/guide/notice-files/NOT-TR-20-012.html) What: Supports projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed a Phase I clinical trial to study SARS-CoV-2 and COVID-19 Who should apply: Specific eligibility not listed Award: Dependent upon FOA you apply through Deadline: Dependent upon FOA you apply through NIA [NOSI: Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019 (COVID-19)](https://grants.nih.gov/grants/guide/notice-files/NOT-AG-21-015.html) What: Supports research on the longer-term effects of COVID-19 on the health and well-being of those infected, those caring for the sick and others whose lives were disrupted by the pandemic and its associated mitigation and prevention strategies Who should apply: Anyone with a research interest in COVID-19 and behavioral, social and aging research Award: Dependent upon FOA you apply through Deadline: Open from March 4, 2021 through May 8, 2023 Deadline updated NIAID [NOSI: Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2](https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-065.html) What: Supports investigator-initiated high-risk clinical trials that will augment ongoing and planned clinical trials of therapeutic and vaccine candidates directed against SARS-CoV-2 to evaluate SARS-CoV-2 candidate vaccines, non-vaccine biomedical prevention of SARS-CoV-2 infection and/or COVID-19 and therapeutic approaches to treat COVID-19 Who should apply: Specific eligibility not listed Award: Award and duration not specified Deadline: Rolling through March 14, 2021 NCATS [NOSI: Repurposing Existing to Address the Coronavirus Disease (COVID-19)](https://grants.nih.gov/grants/guide/notice-files/NOT-TR-21-006.html) What: Encourages projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed a Phase I clinical trial for COVID-19 treatment Who should apply: Anyone with a research interest in existing Phase I COVID-19 drugs Award: Dependent upon FOA you apply through Deadline: Open through March 16, 2021 NCI [NOSI: Administrative Supplement Opportunity to Study the Impact of COVID-19 on Global Cancer Prevention and Control](https://grants.nih.gov/grants/guide/notice-files/NOT-CA-21-033.html) What: Supports NCI-funded investigators who have existing relationships/partnerships in low- and middle-income countries, inclusive of upper-middle-income countries, to leverage those partnerships to conduct research on the pandemic's impact on cancer prevention, diagnosis, treatment and outcomes Who should apply: PIs with an active award eligible for [PA-20-272](https://grants.nih.gov/grants/guide/pa-files/pa-20-272.html) supported through NCI with sufficient time (minimum one year) left to complete the studies proposed after the revision/supplement has been awarded within the existing project period Award: Up to $125,000/one year Deadline: March 31, 2021 New this week! NIGMS [NOSI: Urgent Competitive Revisions to IDeA and NARCH Programs for SARS-CoV-2 Surveillance Studies](https://grants.nih.gov/grants/guide/notice-files/NOT-GM-21-031.html) What: Funds to supplement active Institutional Development Award (IDeA, P20, P30, and U54) and Native American Research Centers for Health (NARCH) (S06) awards for surveillance studies of SARS-CoV-2 viral strains Who should apply: Active grantees of IDeA, P20, P30, and U54 and Native American Research Centers for Health (NARCH) (S06) awards Award: Up to $500,000/one year Deadline: March 31, 2021, 5 p.m. PT NIDA [NOSI: Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19](https://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-017.html) What: Supports research focused on individuals with HIV who smoke or vape marijuana, tobacco, cocaine and/or methamphetamine to determine the long-term effects of their use among individuals with HIV and COVID-19 Who should apply: Anyone with a research interest in COVID-19 and HIV-positive individuals with substance use disorders Award: Dependent upon FOA you apply through Deadline: Open from May 5, 2021 through Sept. 7, 2024 NIDA [NOSI: Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders](https://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-018.html) What: Supports research focused on studying the long-term neurocognitive consequences of the COVID-19/HIV/SUDs syndemic Who should apply: Anyone with a research interest in COVID-19 and HIV-positive individuals with substance use disorders Award: Dependent upon FOA you apply through Deadline: Open from May 7, 2021 through Sept. 7, 2024 NCATS [NOSI: Availability of Emergency Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs](https://grants.nih.gov/grants/guide/notice-files/NOT-TR-21-011.html) What: Administrative supplements from current Clinical and Translational Science Award UL1 component award recipients from these FOAs: [PAR-18-940](https://grants.nih.gov/grants/guide/pa-files/PAR-18-940.html), [PAR-18-464](https://grants.nih.gov/grants/guide/pa-files/par-18-464.html), [PAR-15-304](https://grants.nih.gov/grants/guide/pa-files/PAR-15-304.html) and [RFA-TR-14-009](https://grants.nih.gov/grants/guide/rfa-files/RFA-TR-14-009.html) Who should apply: Current and Translational Science Award UL1 component award recipients Award: Up to $60,000/one year Deadline: Rolling through June 1, 2021 NIDA [NOSI: Effects of smoking and vaping on the risk and outcome of COVID-19 infection](https://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-011.html) What: Supports research on the effects of smoking or vaping tobacco or marijuana on the risk of acquiring COVID-19 and the clinical course of the infection Who should apply: Anyone with a research interest in COVID-19 and smoking and vaping Award: Dependent upon FOA you apply through Deadline: Open from June 5, 2021 through Sept. 7, 2024 NIDCR [NOSI: NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19)](https://grants.nih.gov/grants/guide/notice-files/NOT-DE-21-001.html) What: Supports research studies focused on the physiological involvement of oral cavity and oral manifestations related to SARS-CoV-2 and/or COVID-19 Who should apply: Anyone with a research interest in COVID-19 and the oral cavity Award: Dependent upon FOA you apply through Deadline: Open from June 5, 2021 through May 8, 2023 NIAID [NOSI on Pan-Coronavirus Vaccine Development Program Projects](https://grants.nih.gov/grants/guide/notice-files/NOT-AI-21-002.html) What: Supports research that incorporates understanding of CoV virology and immunology, immunogen design and vaccine and adjuvant platforms and technologies to discover, design and develop pan-coronavirus vaccine candidates that provide broad protective immunity to multiple CoV strains Who should apply: Anyone with a research interest in pan-coronavirus vaccines Award: Not limited/up to five years Deadline: June 11, 2021 NIAID [NOSI: Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2](https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-065.html) What: Supports investigator-initiated high-risk clinical trials that will augment ongoing and planned clinical trials of therapeutic and vaccine candidates directed against SARS-CoV-2 to evaluate SARS-CoV-2 candidate vaccines, non-vaccine biomedical prevention of SARS-CoV-2 infection and/or COVID-19 and therapeutic approaches to treat COVID-19 Who should apply: Specific eligibility not listed Award: Award and duration not specified Deadline: Rolling through March 14, 2021 NIAMS [Notice of Special Interest: Promoting Research on COVID-19 Musculoskeletal and Skin Diseases](https://grants.nih.gov/grants/guide/notice-files/NOT-AR-21-012.html) What: Encourages basic, translational, pre-clinical and clinical observational research focused on COVID-19 infection and its intersection with rheumatic, musculoskeletal, and skin diseases and conditions Who should apply: Anyone with a research interest in COVID-19 and diseases within the NIAMS mission Award: Dependent upon FOA you apply through Deadline: Open through Nov. 18, 2021 Multiple NIH Organizations [NOSI: Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities](https://grants.nih.gov/grants/guide/notice-files/NOT-MD-21-008.html) What: Supports research strategies and interventions to address vaccine hesitancy, uptake and implementation among populations who experience health disparities in the US Who should apply: Anyone with a research interest in vaccine hesitancy Award: Not limited/up to five years Deadline: Open through Jan. 8, 2022 NCATS [NOSI regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus](https://grants.nih.gov/grants/guide/notice-files/NOT-TR-20-016.html) What: Supports research on the use of microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection Who should apply: Anyone with funding through the NIH Microphysiological Systems Program, microphysiological systems programs from across NIH and SBIR/STTR-supported investigators provided the award involves tissue chips Award: No more than 25 percent of the total costs of the amount of the parent award/up to one year Deadline: Open through Jan. 25, 2022 NIDCD [NOSI: NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders](https://grants.nih.gov/grants/guide/notice-files/NOT-DC-20-008.html) What: Supports research on COVID-19 in relation to NIDCD's scientific programs of hearing, balance, taste, smell, voice, speech and language Who should apply: Specific eligibility not listed Award: Dependent upon FOA you apply through Deadline: Open through Sept. 8, 2022 Multiple NIH Organizations [NOSI: Simulation Modeling and Systems Science to Address Health Disparities](https://grants.nih.gov/grants/guide/notice-files/NOT-MD-20-025.html) What: Supports investigative and collaborative research focused on developing and evaluating simulation modeling and systems science to understand and address minority health and health disparities, including those related to COVID-19 Who should apply: Anyone with a research interest in modeling systems and health disparities Award: Not limited/up to five years Deadline: Open through May 8, 2023 NICHD [Notice of Special Interest (NOSI) - Research on Rehabilitation Needs Associated with the COVID-19 Pandemic](https://grants.nih.gov/grants/guide/notice-files/NOT-HD-20-031.html) What: Encourages research to address the rehabilitation needs of survivors of COVID-19, understand the impact of disruptions to rehabilitation services caused by the COVID-19 pandemic and associated mitigation actions and understand the social, behavioral, economic, and health impact of the COVID-19 pandemic and the associated mitigation actions on people with physical disabilities Who should apply: Anyone with a research interest in rehabilitation and COVID-19 Award: Award and duration not specified Deadline: Open through May 8, 2023 NIMH [Notice of Special Interest: Administrative Supplements for COVID-19 Impacted NIMH Research](https://grants.nih.gov/grants/guide/notice-files/NOT-MH-21-120.html) What: Supports administrative supplements to cover unanticipated costs caused by the COVID-19 pandemic or related mitigation efforts that could not be covered by rebudgeting existing funds Who should apply: Investigators and institutions with active NIMH awards that have been significantly impacted by COVID-19 Award: No more than the parent award/no longer than the parent award Deadline: Open through June 1, 2023 NICHD and ORWH [Notice of Special Interest: Emerging Viral Infections and their Impact on the Male and Female Reproductive Tract](https://grants.nih.gov/grants/guide/notice-files/NOT-HD-20-021.html) What: Supports applications proposing cutting-edge research on emerging viral infections including COVID-19 and Zika that are thought to primarily impact non-reproductive sites, at least at initial presentation, but may also affect the male and/or female reproductive tract Who should apply: Anyone with a research interest in viral infections and reproductive tracts Award: Dependent upon the parent award you apply through Deadline: Open through July 16, 2023 NCATS [NOSI: Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs](https://grants.nih.gov/grants/guide/notice-files/NOT-TR-21-017.html) What: Supplements for projects that address the COVID-19 Public Health Emergency through Clinical and Translational Science Award Program recipients Who should apply: Active Clinical and Translational Science Award UL1 component award recipients Award: No more than the parent award/up to two years Deadline: Open through Aug. 16, 2024 NIDA [NOSI: Effects of smoking and vaping on the risk and outcome of COVID-19 infection](https://grants.nih.gov/grants/guide/notice-files/NOT-DA-20-084.html) What: Supports research on the effects of smoking or vaping tobacco or marijuana on the risk of acquiring COVID-19 and the clinical course of the infection Who should apply: Dependent upon FOA you apply through Award: Award and duration not specified Deadline: Open through Sept. 8, 2024 Notices of Intent to Publish NIMHD [Notice of Intent to Publish a Funding Opportunity Announcement for Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities](https://grants.nih.gov/grants/guide/notice-files/NOT-MD-21-007.html) What: Solicits applications for research highlighting the important need for community-engaged research to address vaccine hesitancy, uptake and implementation among populations who experience health disparities Who should apply: Not specified Award: Not specified Deadline: Estimated to be in Feb. 2021 NIAAA Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use [(R01 Clinical Trials Not Allowed)](https://grants.nih.gov/grants/guide/notice-files/NOT-AA-21-001.html), [(R03 Clinical Trials Not Allowed)](https://grants.nih.gov/grants/guide/notice-files/NOT-AA-21-002.html) and [(R21 Clinical Trials Not Allowed)](https://grants.nih.gov/grants/guide/notice-files/NOT-AA-21-003.html) What: Solicits applications for addressing urgent, time-sensitive research questions on the relationships between alcohol consumption/misuse and COVID-19 related outcomes and consequences Who should apply: Anyone with a research interest in COVID-19 and alcohol use Award: For R01: Up to $250,000 per year; For R03: to per R21: to $150,000 per year; all durations not specified Deadline: Estimated to be published Feb. 15, 2021 and estimated deadline April 15, 2021 Other Federal Organizations NSF NSF [Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19)](https://www.nsf.gov/pubs/2020/nsf20052/nsf20052.pdf) What: Calls for proposals to conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19; apply through [existing funding opportunities](https://www.nsf.gov/funding/) and the Rapid Response Research funding mechanism Who should apply: No specific eligibility guidelines; direct proposals either to a program officer managing an NSF program with which the research would be aligned or to [rapid-covid19@nsf.gov](mailto:rapid-covid19@nsf.gov) Award: Up to $200,000/up to one year for RAPID proposals Deadline: Open NSF [Rapid Response Research (RAPID) Funding Mechanism](https://www.nsf.gov/pubs/policydocs/pappg19_1/pappg_2.jsp#IIE1) What: Proposal used when there is a severe urgency with regard to availability of or access to data, facilities or specialized equipment, including quick-response research on natural or anthropogenic disasters and similar unanticipated events Who should apply: No specific eligibility guidelines; direct proposals either to a program officer managing an NSF program with which the research would be aligned or to [rapid-covid19@nsf.gov](mailto:rapid-covid19@nsf.gov) Award: Up to $200,000/up to one year Deadline: Open Private Organizations ImpactAssets [Stop the Spread COVID Response Program](https://www.stopthespread.org/) What: Call to companies and organizations to spur development of PPE for both medical and non-medical use, novel testing solutions, widely-accessible therapeutics and digital health solutions to address the needs of underserved communities and vulnerable populations Who should apply: Anyone with a research interest in PPE Award: Not limited Deadline: Not specified Oak Ridge National Laboratory [Call for Rapid Access Proposals for COVID-19 Research](https://snsapp1.sns.ornl.gov/xprod_ro/f?p=109:26:0:) What: Supports research into the COVID-19 virus and the search for effective diagnostics and therapies through the use of neutron macromolecular crystallography, small angle scattering, reflectometry, spectroscopy and imaging beamlines Who should apply: Researchers who would like to use these resources should submit a short rapid access proposal, outlining experiment aims and scope Award: Access to the beamlines at the Spallation Neutron Source (SNS) and High Flux Isotope Reactor (HFIR) at Oak Ridge National Laboratory Deadline: Rolling Robert Wood Johnson Foundation [Pioneering Ideas: Exploring the Future to Build a Culture of Health](https://www.rwjf.org/en/library/funding-opportunities/2020/pioneering-ideas-2020-exploring-the-future-to-build-a-culture-of-health.html?rid=0034400001rlqDeAAI&et_cid=2046258) What: Supports proposals to address any of these four areas of focus: Future of Evidence, Future of Social Interaction, Future of Food and Future of Work; not directly aimed at COVID-19 but proposals can be related to the pandemic Who should apply: Anyone who wants to research COVID-19 and health equity Award: No minimum or maximum, average amount $315,031/generally between one to three years Deadline: Rolling This organization is on the [President's List](https://o2.ohsu.edu/foundations/research-program-grants/ohsu-presidents-list/index.cfm); submit a [notice of intent form](https://app.smartsheet.com/b/form?EQBCT=b4b914967b774308b1947bbf8ab27b15) before applying New this week! Simons Foundation Autism Research Initiative [Maternal COVID-19 as a potential risk for autism: Supplemental funding for ongoing pregnancy cohorts](https://www.sfari.org/grant/maternal-covid-19-as-a-potential-risk-for-autism-supplemental-funding-for-ongoing-pregnancy-cohorts-request-for-applications/?tab=rfa) What: Supplements funding from other agencies for ongoing pregnancy cohorts to broaden biospecimen collection and to extend post-natal family tracking so they can be leveraged in future research to understand the effects of gestational infection and inflammation on autism risk in children Who should apply: Researcher who have existing pregnancy cohorts who would like to study the effects of COVID-19 infection during pregnancy Award: Up to $250,000 for single sites and up to $400,000 for two or more sites/three years Deadline: March 12, 2021 This organization is on the [President's List](https://o2.ohsu.edu/foundations/research-program-grants/ohsu-presidents-list/index.cfm); submit a [notice of intent form](https://app.smartsheet.com/b/form?EQBCT=b4b914967b774308b1947bbf8ab27b15) before applying Christopher & Dana Reeve Foundation National Paralysis Resource Center [Quality of Life Grants](https://www.christopherreeve.org/blog/daily-dose/quality-of-life-grant-cycle-opens-february-2-2021) What: Supports paralysis research through two mechanisms: Direct Effect grants fund projects that clearly impact individuals living with paralysis and their families and caregivers, and COVID-19: Addressing Social Isolation grants fund research to enhance the connectedness of people living with paralysis and their caregivers to their communities Who should apply: Paralysis researchers; note that special consideration will be given to projects that serve current military and/or veterans and their families and projects that target underserved individuals with paralysis Award: For Direct Effect: Up to $25,000/one year; For to $50,000/one year Deadline: March 8:59 p.m. PT Multiple organizations [The Trinity Challenge](https://thetrinitychallenge.org/frequently-asked-questions/) What: Global organizations including the Bill and Melinda Gates Foundation, Facebook and Google granting significant support and awards to the best contributions around pandemic preparedness and response Who should apply: Anyone with a research interest in pandemic preparedness Award: Funding drawn from an approximately $13.1 million pool (converted from pounds) Deadline: April 15, 2021 for independent teams to submit the results of their projects and be considered for a share of the prize fund in the inaugural round "}